Loading…
Chinese hospital-management and healthcare-services group operating a network of private hospitals.
Chinese hospital-management and healthcare-services group operating a network of private hospitals.
Moat: narrow (regulatory licence, scale). Hospital operating licences and an existing multi-hospital network create local barriers to entry.
Headquarters: China · Employees: 2,572
Size Innovation Medical Management (002173.SZ) is a China Industrials company (Wholesale Distributors) with a market value of $1.12B, the 2085th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥16.42 on 6 Nov 2026.
Performance Over six months the shares fell 29.4%, against -10.4% for the median peer and -16.4% for the China market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue fell 13.3% over the last twelve months (peer median +10.4%); the operating margin is -17.9% (peer median 7.2%).
Valuation It trades at 10.2× enterprise value to sales against a peer median of 1.3× (most expensive of 20).
Capital Return on invested capital runs 11.5 points below its cost of capital (8.9% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥696M | CN¥781M | CN¥816M | CN¥805M | CN¥710M |
| Revenue growth | — | -4% | +1% | +13% | — |
| Gross profit | CN¥69.2M | CN¥40.9M | CN¥49.1M | CN¥74.2M | CN¥11.5M |
| EBITDA | n/a | CN¥39.1M | CN¥45.0M | CN¥75.7M | CN¥30.6M |
| Net income | -CN¥121M | -CN¥34.9M | -CN¥94.0M | -CN¥34.3M | -CN¥73.4M |
| Free cash flow | -CN¥57.8M | -CN¥8.59M | -CN¥53.9M | -CN¥85.2M | -CN¥130M |
| Capital expenditure | CN¥47.8M | CN¥84.5M | CN¥47.0M | CN¥96.2M | CN¥123M |
| Total debt | CN¥85.6M | CN¥82.3M | CN¥77.2M | CN¥68.5M | CN¥60.2M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Innovation Medical Management 002173.SZ | $1.12B | -29% | -13% | -18% | 10.2× | n/a |
| Aier Eye Hospital 300015.SZ | $12.5B | -16% | +5% | 21% | 3.7× | 11.7% |
| China Resources Medical 1515.HK | $415M | -12% | 0% | 6% | 0.5× | -7.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 002173.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -4.0% | -6.6% | 8th highest of 21 |
| 6-month return | -29.4% | -10.4% | 7th lowest of 21 |
| Distance from 52-week high | -57.1% | -33.1% | 4th lowest of 21 |
| Revenue growth (TTM) | -13.3% | +10.4% | lowest of 20 |
| Operating margin | -17.9% | 7.2% | lowest of 20 |
| EV / Sales | 10.2× | 1.3× | most expensive of 20 |
| ROIC minus cost of capital | -11.5 pp | +1.8 pp | 2nd lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Innovation Medical Management 002173.SZ | China | $1.12B | -29% | -13% | -18% | 10.2× | n/a | n/a |
| Brighton-Best International (Taiwan) 8415.TWO | Taiwan | $1.11B | +5% | +11% | 20% | 1.9× | -8.8% | +8.8% |
| Daiichikosho 7458.T | Japan | $1.13B | +6% | +4% | 11% | 1.2× | -6.0% | +11.8% |
| Dongguan Aohai Technology 002993.SZ | China | $1.10B | -44% | +122% | 1% | 0.6× | n/a | n/a |
| Imdex IMD.AX | Australia | $1.15B | -21% | +21% | 16% | 3.7× | 20.1% | +14.5% |
| Techstorm Advanced Material 601026.SS | China | $1.16B | -33% | +8% | 6% | 2.4× | n/a | n/a |
| Chengdu Haoneng Technology 603809.SS | China | $1.16B | -23% | +18% | 10% | 3.7× | n/a | n/a |
| BayWa BYW.DE | Germany | $1.07B | -58% | n/a | n/a | n/a | n/a | n/a |
| Supply Network SNL.AX | Australia | $1.06B | +12% | +16% | 17% | 3.9× | 11.7% | +19.9% |
| Zhejiang Songyuan Automotive Safety Systems 300893.SZ | China | $1.06B | -34% | +27% | 12% | 2.8× | n/a | n/a |
| Beijing Geekplus Technology 2590.HK | Hong Kong | $1.05B | -67% | +33% | 0% | 1.5× | n/a | n/a |
| China Agricultural Development Seed 600313.SS | China | $1.04B | -16% | +35% | 1% | 0.8× | 21.8% | +12.7% |
| Redox RDX.AX | Australia | $1.22B | +2% | +7% | 11% | 1.3× | -7.8% | +10.8% |
| Totech 9960.T | Japan | $1.00B | 0% | +6% | 10% | 0.9× | 5.4% | +9.2% |
| Deep Source 0990.HK | Hong Kong | $1.00B | -31% | +7% | 2% | 0.2× | -13.6% | +6.1% |
| Gansu Guofang Industry & Trade (Group) 601086.SS | China | $1.27B | +42% | +17% | 7% | 9.3× | 33.6% | -4.8% |
| Yamazen 8051.T | Japan | $978M | +13% | +7% | 2% | 0.2× | -6.3% | +4.5% |
| Trusco Nakayama 9830.T | Japan | $958M | +6% | +10% | 7% | 0.6× | n/a | n/a |
| Hangzhou Cogeneration 605011.SS | China | $956M | -23% | -1% | 5% | 2.2× | n/a | n/a |
| Inabata & 8098.T | Japan | $1.31B | +6% | +5% | 3% | 0.3× | -7.8% | +7.6% |
| Taikisha 1979.T | Japan | $1.32B | -5% | -1% | 8% | 0.5× | -13.3% | +7.2% |